Tag - CNVI

Developments

China’s NMPA Approves EOM’s Coronary Imaging System Based on Conavi Medical’s IP

Conavi Medical (TSXV:CNVI) has announced that its exclusive licensing partner in China, East Ocean Medical (Hong Kong) Company Limited (EOM), has received approval by the China National Medical Products Administration...

December 9, 2024

Feature

Conavi’s recent RTO fuels trajectory of world’s first and only hybrid intravascular imaging system combining co-registered IVUS + OCT

Conavi Medical (TSXV:CNVI) is leveraging its recent reverse merger (RTO) with Titan Medical to accelerate the wide-spread adoption of its breakthrough imaging platform, the next-generation Novasight Hybrid System...

November 5, 2024

Developments

JACC article highlights emerging hybrid intracoronary imaging technologies like Conavi’s Novasight

Conavi Medical (TSXV:CNVI) has announced that the Journal of the American College of Cardiology: Cardiovascular Interventions (JACC) has published a peer-reviewed article detailing recent advances in hybrid...

October 28, 2024

Developments

Conavi Medical moves stock listing to TSXV following reverse takeover of Titan Medical

After completing its reverse takeover of Titan Medical on October 11th, Conavi Medical has completed its plan to voluntarily delist from the TSX and subsequently list on the TSX Venture Exchange (TSXV). Trading of...

October 16, 2024

Tag - CNVI

China’s NMPA Approves EOM’s Coronary Imaging System Based on Conavi Medical’s IP

Conavi’s recent RTO fuels trajectory of world’s first and only hybrid intravascular imaging system combining co-registered IVUS + OCT

JACC article highlights emerging hybrid intracoronary imaging technologies like Conavi’s Novasight

Conavi Medical moves stock listing to TSXV following reverse takeover of Titan Medical

General

More